Literature DB >> 11212274

A photobiological and photophysical-based study of phototoxicity of two chlorins.

B W Pogue1, B Ortel, N Chen, R W Redmond, T Hasan.   

Abstract

To understand the fundamental determinants of phototoxic efficacy and absorbed photodynamic dose, the triplet state and photobleaching quantum yields in living cells, cellular uptake, intracellular localization, and correlation with cell viability were studied for the two purpurins tin ethyl etiopurpurin 1 (SnET2) and tin octaethylbenzochlorin (SnOEBC) in ovarian cancer cells (OVCAR5). Although the triplet yields of these two photosensitizers were not significantly affected by cellular incorporation, the photobleaching yields were shown to be 3 orders of magnitude higher for cellular-bound sensitizer than for free or albumin-bound photosensitizer and higher for SnET2 than for SnOEBC for all of the cases. The intracellular concentration of SnOEBC was half that of SnET2 after 3 h- and 24 h-incubation times for both 0.1 microM and 1.0 microM incubation concentrations. Despite the lower concentrations of SnOEBC, the phototoxicity of the two photosensitizers was comparable at 1-microM incubation concentration and was up to 10-fold higher for SnOEBC at the lower concentration. The subcellular localization established using confocal microscopy and molecular probes showed that both photosensitizers were primarily lysosomally localized. SnOEBC, however, had an extra-lysosomal, mitochondrial localization component. The photophysical measurements allowed calculation of the intracellular singlet oxygen production, which indicated that the photosensitizer-light dose reciprocity was limited by photobleaching for SnET2 but only minimally for SnOEBC, and this was confirmed through cell-survival studies. Taken together, these data indicate that the critical determinant of differences in phototoxicity between the two molecules was their relative rates of photobleaching and their subcellular localization. The study points to the importance of combining photosensitizer uptake and localization with photophysical measurements in the relevant biological milieu to reasonably interpret and/or predict photosensitization efficacies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212274

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration.

Authors:  Sulbha K Sharma; Michael Krayer; Felipe F Sperandio; Liyi Huang; Ying-Ying Huang; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Porphyr Phthalocyanines       Date:  2013-01       Impact factor: 1.811

2.  In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers.

Authors:  Ying-Ying Huang; Pawel Mroz; Timur Zhiyentayev; Sulbha K Sharma; Thiagarajan Balasubramanian; Christian Ruzié; Michael Krayer; Dazhong Fan; K Eszter Borbas; Eunkyung Yang; Hooi Ling Kee; Christine Kirmaier; James R Diers; David F Bocian; Dewey Holten; Jonathan S Lindsey; Michael R Hamblin
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

3.  Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells.

Authors:  Adnan O Abu-Yousif; Anne C E Moor; Xiang Zheng; Mark D Savellano; Weiping Yu; Pål K Selbo; Tayyaba Hasan
Journal:  Cancer Lett       Date:  2012-01-18       Impact factor: 8.679

4.  Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells.

Authors:  B Ortel; D Sharlin; D O'Donnell; A K Sinha; E V Maytin; T Hasan
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

Review 5.  Tissue Engineering and Photodynamic Therapy: A New Frontier of Science for Clinical Application -An Up-To-Date Review.

Authors:  Mariza Aires-Fernandes; Camila Fernanda Amantino; Stéphanie Rochetti do Amaral; Fernando Lucas Primo
Journal:  Front Bioeng Biotechnol       Date:  2022-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.